Trial intelligence / Profile preview

Bicyclol for Acute Drug-induced Liver Injury

NCT02944552Phase 2Completed

Sponsor
Spanish Drug-Induced Liver Disease Study Group
Start
Aug 2017
Primary completion
Jun 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of bicyclol in drug induced liver injury (DILI), sponsored by Spanish Drug-Induced Liver Disease Study Group. Started Aug 2017; status: completed.

02

Drugs

bicyclol
03

Conditions

drug induced liver injury (DILI)

Beyond the preview

Go deeper on NCT02944552.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02944552.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call